Office for Technology Commercialization

Living with Pulmonary Hypertension Questionnaire (LPHQ)

Technology #2020-185
The Living with Pulmonary Hypertension Questionnaire (LPHQ) is a reliable and validated measure of the adverse effects of pulmonary hypertension on a patient’s life.

Patient Reported Outcome Questionnaire for Pulmonary Hypertension

The questionnaire is comprised of 21 important physical, emotional and socioeconomic ways pulmonary hypertension can adversely affect a patient’s life. After receiving brief standardized instructions, the patient marks a 0 (zero) to 5 scale to indicate how much each itemized adverse effect of pulmonary hypertension has prevented the patient from living as he or she wanted to live during the past 4 weeks. The questionnaire is simply scored by summation of all 21 responses. This patient-reported outcome can be used to determine whether a treatment for pulmonary hypertension is effective for improving patients’ quality of life by reducing the adverse impact of pulmonary hypertension.

LPHQ Translations

The Questionnaire is available from the University of Minnesota in the English language version only. The LPHQ license allows you to translate the Questionnaire without any further obligations to the University of Minnesota as long as all translations are used for the same study or protocol.


A license from the University of Minnesota is required to use LPHQ for any purpose. Please purchase the license that best matches your intended use. The Questionnaire and supporting materials will be available for download after online completion of license agreement and payment of fees.

LPHQ is 1986-2019 Copyright © of Bayer AG and Regents of the University of Minnesota. All rights reserved.